Cargando…

Harnessing immunity for therapy in human papillomavirus driven cancers

In persistent high-risk HPV infection, viral gene expression can trigger some important early changes to immune capabilities which act to protect the lesion from immune attack and subsequently promote its growth and ability for sustained immune escape. This includes immune checkpoint-inhibitor ligan...

Descripción completa

Detalles Bibliográficos
Autor principal:	Stern, Peter L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942755/ https://www.ncbi.nlm.nih.gov/pubmed/33602657 http://dx.doi.org/10.1016/j.tvr.2021.200212

Ejemplares similares

Harnessing Human Papillomavirus’ Natural Tropism to Target Tumors
por: Kines, Rhonda C., et al.
Publicado: (2022)

Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering
por: Zhong, Justin X., et al.
Publicado: (2022)

DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers
por: Ekanayake Weeramange, Chameera, et al.
Publicado: (2020)

Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy
por: Fatima, Shadma, et al.
Publicado: (2022)

Harnessing the immune system in glioblastoma
por: Brown, Nicholas F., et al.
Publicado: (2018)

Harnessing helminth-driven immunoregulation in the search for novel therapeutic modalities
por: Ryan, Stephanie M., et al.
Publicado: (2020)

Harnessing the immune system in the battle against breast cancer
por: Nakasone, Elizabeth S, et al.
Publicado: (2018)

Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
por: Choi, Yechan, et al.
Publicado: (2023)

Harnessing the immune response to target tumors
por: Manning, Luisa, et al.
Publicado: (2017)

Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention
por: Idres, Yusuf M., et al.
Publicado: (2022)

Harnessing Solar‐Driven Photothermal Effect toward the Water–Energy Nexus
por: Zhang, Chao, et al.
Publicado: (2019)

Harnessing the Nucleolar DNA Damage Response in Cancer Therapy
por: Xuan, Jiachen, et al.
Publicado: (2021)

Harnessing DNA Replication Stress for Novel Cancer Therapy
por: Zhu, Huanbo, et al.
Publicado: (2020)

Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer
por: Dhital, Brittiny, et al.
Publicado: (2023)

Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics
por: Le, Ilene, et al.
Publicado: (2022)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer
por: Neo, Shi Yong, et al.
Publicado: (2023)

Harnessing RNAi nanomedicine for precision therapy
por: Peer, Dan
Publicado: (2014)

Harnessing the Immune System to Fight Multiple Myeloma
por: Krejcik, Jakub, et al.
Publicado: (2021)

Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment
por: Elion, David L., et al.
Publicado: (2018)

Therapeutics to harness the immune microenvironment in multiple myeloma
por: Ignatz-Hoover, James J., et al.
Publicado: (2022)

Harnessing Immune Response in Acute Myeloid Leukemia
por: Riva, Carola, et al.
Publicado: (2023)

Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis
por: Bastos, Reginaldo G., et al.
Publicado: (2022)

Harnessing cancer stem cell-derived exosomes to improve cancer therapy
por: Yang, Jianqiang, et al.
Publicado: (2023)

Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer
por: Hatano, Takashi, et al.
Publicado: (2021)

Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses
por: Sullivan, Meghan, et al.
Publicado: (2011)

Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
por: Bae, Jihong, et al.
Publicado: (2022)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Harnessing Cellular Immunity for Vaccination against Respiratory Viruses
por: Lukacs, Nicholas W., et al.
Publicado: (2020)

Harnessing the liver to induce antigen-specific immune tolerance
por: Gottwick, Cornelia, et al.
Publicado: (2022)

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus
por: Kash, Natalie, et al.
Publicado: (2015)

Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins
por: Lo Cigno, Irene, et al.
Publicado: (2020)

Harnessing nanoparticles for immune modulation
por: Getts, Daniel R., et al.
Publicado: (2015)

Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
por: Andorko, James I., et al.
Publicado: (2014)

De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancer
por: An, Yi, et al.
Publicado: (2016)

Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer
por: Kather, Jakob Nikolas, et al.
Publicado: (2019)

Cancer Immunotherapy: Harnessing the Immune System to Fight Cancer
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008)

Harnessing the antitumor potential of macrophages for cancer immunotherapy
por: Long, Kristen B, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_utqn26gc7caq0pc49v664fgqhd